Does Blue Cross Blue Shield of Alabama Cover Semaglutide (Wegovy)?

HealthRX.com

BCBS Alabama coverage depends on the specific plan

Print or save as PDF

Key numbers

  • 86.4%Share of STEP 1 adults on semaglutide who reached at least 5% weight loss, versus 31.5% on placeboSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 31.5%Share of STEP 1 adults on placebo who reached at least 5% weight lossSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 50.5%Share of STEP 1 adults on semaglutide who reached at least 15% weight lossSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 4.9%Share of STEP 1 adults on placebo who reached at least 15% weight lossSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026

See the public record for Semaglutide

At a glance

  • What Wegovy treats / Weight reduction and CV risk reduction (injection and tablet); MASH (injection only) [1]
  • Forms / Weekly injection and a once-daily 25 mg tablet for adults [1]
  • Approval dates / Wegovy injection 2021-06-04; Wegovy tablets 2025-12-22 [2][3]
  • Prescription status / Prescription-only; none sold over the counter [1]
  • Ozempic / A separate approval for type 2 diabetes, with no weight-loss indication [1][4]
  • Compounded semaglutide / Not FDA approved and not reviewed for safety, effectiveness or quality [5]

What the Wegovy label covers

The Wegovy injection label lists three uses, each alongside a reduced-calorie diet and increased physical activity: reducing the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight; reducing excess body weight and maintaining the loss in adults and children aged 12 and older with obesity, and in adults with overweight plus at least one weight-related condition; and treating noncirrhotic MASH with moderate to advanced fibrosis (stages F2 to F3) in adults, under accelerated approval [1].

Wegovy comes as a weekly injection and a once-daily 25 mg tablet. The injection was approved on 2021-06-04 [2]. The tablet was approved on 2025-12-22 and is for adults only: it is indicated for weight reduction and cardiovascular risk reduction, and the label gives it no pediatric or MASH indication [1][3].

The label also carries a limitation of use: taking Wegovy with another semaglutide-containing product or with any other GLP-1 receptor agonist is not recommended [1].

Questions worth asking

Choose the questions you want to keep

Ozempic is a different approval

Ozempic contains semaglutide too, but it is approved for type 2 diabetes (NDA 209637, original approval 2017-12-05) and has no weight-loss indication [1][4]. Wegovy sits under NDA 215256 [2].

What people on Reddit report

Reddit accounts from people trying to get Wegovy approved under a Blue Cross Blue Shield plan, including one with a BCBS Alabama plan through an employer. They describe the formulary and approval rules they ran into.

Impossible-Bus9185 · WegovyWeightLoss

Has anyone had any luck getting Wegovey under BCBS of Alabama? I live in PA but our insurance is BCBS of Alabama and it doesn't look like we can get it with an RX and a PA.

Asks whether anyone has gotten Wegovy covered under a BCBS Alabama plan. They live in another state but are on that plan through a spouse's employer.

Read the source discussion

Impossible-Bus9185 · WegovyWeightLoss

Thank you. Unfortunately, I think i'm out of luck. I wish insurance would catch on and start covering these drugs. We have the most comprehensive plan offered by my husbands employer and it's only covering Ozempic if you are diabetic.

Reports that their employer plan covers Ozempic only for people with diabetes, so they expect Wegovy to be out of reach.

Read the source discussion

Impossible-Bus9185 · WegovyWeightLoss

It's listed as a 4+ tier designation. Ozempic is 3 with step therapy and to your point you need to be diabetic.

Found the plan's drug tier listing and reports that Wegovy sits in a higher cost tier than Ozempic, which also requires step therapy.

Read the source discussion

Carly_Corthinthos · WegovyWeightLoss

Look on your formulary list. It will say criteria. They won't over ozempic for non diabetics but will cover wegovy if your bmi is over 35 I think.

Advises checking the formulary criteria. Says their plan approved Wegovy based on a BMI rule rather than diabetes, but is not sure of the exact cutoff.

Read the source discussion

The weight-loss results behind the indication

STEP 1 was a double-blind, 68-week trial of 1,961 adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition, and no diabetes. Mean weight change was -14.9% with semaglutide 2.4 mg weekly versus -2.4% with placebo. At least 5% weight loss was reached by 86.4% on semaglutide and 31.5% on placebo; at least 15% by 50.5% and 4.9% [6].

Compounded semaglutide is not an approved product

FDA says compounded drugs are not FDA approved and are not reviewed for safety, effectiveness or quality before they are marketed [5]. FDA declared the semaglutide injection shortage resolved on 2025-02-21, and the enforcement discretion that had allowed shortage-based compounding ended in 2025 [7].

Check what you know

Think you have it? Try 3 quick questions and see what the article says.

1. According to the article, what forms does Wegovy come in?

Question 1 of 3

Score: 0 right, 0 of 3 answered

Frequently asked questions

Does BCBS Alabama cover Wegovy?
That depends on the individual plan's formulary and prior-authorization terms, and this page has no plan-specific answer. Wegovy is an FDA-approved prescription semaglutide product for weight reduction and CV risk reduction, and the injection is also approved for MASH [1].
What is Wegovy FDA approved to treat?
Weight reduction in adults and children 12 and older with obesity and in adults with overweight plus a weight-related condition; CV risk reduction in adults with established cardiovascular disease and obesity or overweight; and, for the injection, noncirrhotic MASH with F2 to F3 fibrosis under accelerated approval. The tablet is for adults and is not indicated for MASH [1].
Is Ozempic coverage the same as Wegovy coverage?
They are separate FDA approvals. Ozempic (NDA 209637, approved 2017-12-05) is approved for type 2 diabetes and has no weight-loss indication; Wegovy is approved under NDA 215256 [1][2][4].
Is the Wegovy pill covered the same way as the injection?
They are different products under different approvals - the injection under NDA 215256 (2021-06-04) and the 25 mg tablet under NDA 218316 (2025-12-22) - and the tablet is approved for adults only [1][2][3].
What weight loss did the Wegovy trials show?
In STEP 1, 1,961 adults with obesity or overweight and no diabetes had a mean weight change of -14.9% on semaglutide 2.4 mg versus -2.4% on placebo at 68 weeks; at least 5% weight loss occurred in 86.4% versus 31.5% [6].
Does BCBS Alabama cover compounded semaglutide?
This page has no BCBS Alabama information on compounded products. FDA says compounded semaglutide is not FDA approved and is not reviewed for safety, effectiveness or quality, and it declared the semaglutide injection shortage resolved on 2025-02-21 [5][7].

References

Show all 8 referencesHide references
  1. U.S. National Library of Medicine, DailyMed. Wegovy injection and tablets prescribing information. Wegovy injection and tablets label
  2. Drugs@FDA: FDA-Approved Drugs.
  3. Drugs@FDA: FDA-Approved Drugs.
  4. Drugs@FDA: FDA-Approved Drugs.
  5. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA.
  6. Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
  7. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize | FDA.
  8. Reddit participants. Wegovy Approval for BCBS AL? (r/WegovyWeightLoss). Accessed 2026-11-10.
Blue cross blue shield alabama wegovy: evidence summary chart
Image: HealthRX.com. Full blue cross blue shield alabama wegovy guide and sources at healthrx.com/glp-1-faq.